Journal article
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
Abstract
Background The high positivity rate of prostate-specific membrane antigen (PSMA) PET in the setting of biochemical failure (BCF), even when conventional imaging is negative, is promising. Purpose To assess the disease detection rate of PSMA-based PET/CT with fluorine 18-DCFPyL as a radiotracer and the PET-directed management change in men with suspected limited recurrent prostate cancer. Materials and Methods This prospective multicenter …
Authors
Metser U; Zukotynski K; Mak V; Langer D; MacCrostie P; Finelli A; Kapoor A; Chin J; Lavallée L; Klotz LH
Journal
Radiology, Vol. 303, No. 2, pp. 414–422
Publisher
Radiological Society of North America (RSNA)
Publication Date
May 2022
DOI
10.1148/radiol.211824
ISSN
0033-8419